U.S. Food and Drug Administration, Center for Drug Evaluation and Research

FDA Drug Safety Podcasts

Rimani informato con discussioni approfondite sugli aggiornamenti sulla sicurezza dei farmaci e le comunicazioni della FDA, aiutandoti a fare scelte migliori per la tua salute e il tuo benessere.

Listen on Apple Podcasts

Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic acid) to treat primary biliary cholangitis

5 mins • Jan 2, 2025

Episodi recenti

Jan 2, 2025

Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic acid) to treat primary biliary cholangitis

5 mins

Sep 20, 2024

FDA adds warning about rare occurrence of serious liver injury with use of Veozah (fezolinetant) for hot flashes due to menopause

4 mins

Feb 6, 2024

FDA adds Boxed Warning for increased risk of severe hypocalcemia in patients with advanced chronic kidney disease taking osteoporosis medicine Prolia (denosumab)

4 mins

Jan 26, 2024

Update on FDA’s ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity

4 mins

Dec 8, 2023

FDA warns of rare but serious drug reaction to the antiseizure medicines levetiracetam (Keppra, Keppra XR, Elepsia XR, Spritam) and clobazam (Onfi, Sympazan)

5 mins

Lingua
Inglese
Paese
Australia
Sito web